Drugs / LEO 35299
last change Jun 2012 re-read 2 minutes ago

LEO 35299

Developed for
psoriasis
Investigated by
LEO Pharma

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01580488 Apr → Jun 2012 psoriasis LEO Pharma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LEO 35299 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01580488
Route Topical “B LEO 35299 20 mg/g cream” NCT01580488